Each person’s cancer has a unique combination of genetic changes, and tumor DNA sequencing is a test to identify these unique DNA changes. In some cases, knowledge of the genetic alterations in a cancer can help determine a treatment plan. Our Diverse DNA cancer screening division has multiple oncology practices across the country where samples are collected and tested for DNA mutations that give insight to oncologist for heading off cancer before it becomes life threatening to their patients.
Our Diverse DNA division provides meticulousness, next-generation DNA sequencing tools, to arm physicians and patients with personalized treatment information
Hereditary Cancer Screenings (CGX) – to understand if a patient is predisposed to acquiring cancer
Pharmacogenomics Testing (PGX) – to show how a patient’s body is likely to metabolize many common medications.
Diverse DNA, a division of Diverse Biotech synergizes the teams specialized knowledge, partnerships and cutting edge DNA sequencing tests provide our clients with best-in-class solutions. We are committed to providing a full range of DNA sequencing tests with a mission to extend or save lives. That’s our biggest goal.
Diverse DNA’s buccal swab program advances research capabilities with cutting-edge technology to improve patient care and cancer treatment through early detection. Diverse DNA’s cancer screenings are a preventative cancer strategy.
Our cancer-screening program is compromised of lab techs, administrative personnel, and DNA sequencing technology, but it offers something more – a team who care.
In addition to the genetic testing, we also offer comprehensive health and wellness tests such as: